World leaders' war on Oil is fueling lithium demand and this one company is set to dominate...
Discover It Here. |
|
69% a year return. One type of stock. Really? (ad) |
Why settle for puny 4% or 5% yields. My portfolio pays out a 69% cash on cash return. It's not magic. Or wishful thinking. I just buy one type of regular stock. No leverage, options, or gimmicks required.
Get All the Details Now... |
|
You have not added any stocks to your watchlist. Click here to add stocks to your watchlist. - Ameren (NYSE:AEE) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $89.00 price target on the stock, up previously from $84.00.This represents a 9.1% upside from the current price of $81.61. Read More.
- Aviva (OTCMKTS:AVVIY) was upgraded by analysts at Investec to a "buy" rating.The current price is $11.18. Read More.
- Babcock International Group (OTCMKTS:BCKIF) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating.The current price is $3.14. Read More.
- P/F Bakkafrost (OTCMKTS:BKFKF) was upgraded by analysts at Pareto Securities from a "sell" rating to a "hold" rating.The current price is $75.74. Read More.
- Booking (NASDAQ:BKNG) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $2,800.00 price target on the stock, up previously from $2,300.00.This represents a 16.9% upside from the current price of $2,395.71. Read More.
- Bristol-Myers Squibb (NYSE:BMY) was upgraded by analysts at Truist from a "hold" rating to a "buy" rating.The current price is $63.11. Read More.
- Bristol-Myers Squibb (NYSE:BMY) was upgraded by analysts at Truist Securities to a "buy" rating. They now have a $74.00 price target on the stock, up previously from $66.00.This represents a 17.3% upside from the current price of $63.11. Read More.
- BancorpSouth Bank (NYSE:BXS) was upgraded by analysts at Hovde Group from a "market perform" rating to an "outperform" rating. They now have a $36.00 price target on the stock.This represents a 20.2% upside from the current price of $29.95. Read More.
- CommScope (NASDAQ:COMM) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $21.00 price target on the stock, up previously from $14.00.This represents a 21.0% upside from the current price of $17.35. Read More.
- Getinge (OTCMKTS:GNGBY) was upgraded by analysts at DNB Markets from a "hold" rating to a "buy" rating.The current price is $29.83. Read More.
- Gran Tierra Energy (NYSEAMERICAN:GTE) was upgraded by analysts at Scotiabank from an "underperform" rating to a "sector perform" rating.The current price is $0.64. Read More.
- iHeartMedia (NASDAQ:IHRT) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $26.00 price target on the stock.This represents a 36.1% upside from the current price of $19.10. Read More.
- JetBlue Airways (NASDAQ:JBLU) was upgraded by analysts at Susquehanna from a "neutral" rating to a "positive" rating. They now have a $26.00 price target on the stock.This represents a 28.5% upside from the current price of $20.23. Read More.
- JetBlue Airways (NASDAQ:JBLU) was upgraded by analysts at Susquehanna Bancshares, Inc. from a "neutral" rating to a "positive" rating. They now have a $26.00 price target on the stock.This represents a 28.5% upside from the current price of $20.23. Read More.
- MFA Financial (NYSE:MFA) was upgraded by analysts at Keefe, Bruyette & Woods from a "market perform" rating to an "outperform" rating.The current price is $4.21. Read More.
- The Mosaic (NYSE:MOS) was upgraded by analysts at Berenberg Bank from a "hold" rating to a "buy" rating. They now have a $40.00 price target on the stock.This represents a 24.7% upside from the current price of $32.08. Read More.
- Qiwi (NASDAQ:QIWI) was upgraded by analysts at Sberbank CIB from a "sell" rating to a "hold" rating.The current price is $10.88. Read More.
- Spirit Airlines (NYSE:SAVE) was upgraded by analysts at Susquehanna from a "neutral" rating to a "positive" rating. They now have a $50.00 price target on the stock.This represents a 39.6% upside from the current price of $35.82. Read More.
- Spirit Airlines (NYSE:SAVE) was upgraded by analysts at Susquehanna Bancshares, Inc. from a "neutral" rating to a "positive" rating. They now have a $50.00 price target on the stock.This represents a 39.6% upside from the current price of $35.82. Read More.
- Singapore Exchange (OTCMKTS:SPXCY) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating.The current price is $111.02. Read More.
- Sasol (NYSE:SSL) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating.The current price is $15.29. Read More.
- Supernus Pharmaceuticals (NASDAQ:SUPN) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $40.00 price target on the stock, up previously from $25.00.This represents a 30.7% upside from the current price of $30.60. Read More.
- Teleperformance (OTCMKTS:TLPFY) was upgraded by analysts at AlphaValue to a "reduce" rating.The current price is $194.94. Read More.
- The Weir Group (OTCMKTS:WEGRY) was upgraded by analysts at Credit Suisse Group AG from a "neutral" rating to an "outperform" rating.The current price is $12.85. Read More.
- View today's most recent analysts' upgrades at MarketBeat.com
The World's First $2 Trillion Drug? (ad) |
The Wall Street Journal reports new treatment is "transforming medicine."
Bill Gates writes that it could "help humanity."
Ark Investments think it could be a "$2 trillion market."
And one small company owns the patent on it.
This unknown biotech's stock is set to surge 46,751% >>> |
|
- Acadian Timber (OTCMKTS:ACAZF) was downgraded by analysts at CIBC from a "neutral" rating to an "underperform" rating. They now have a $17.00 price target on the stock.This represents a 7.5% upside from the current price of $15.81. Read More.
- Aphria (NASDAQ:APHA) was downgraded by analysts at Canaccord Genuity from a "buy" rating to a "hold" rating. They now have a $17.50 price target on the stock.This represents a 17.6% upside from the current price of $14.88. Read More.
- Credicorp (NYSE:BAP) was downgraded by analysts at Itau BBA Securities to a "market perform" rating. They now have a $195.00 price target on the stock.This represents a 33.1% upside from the current price of $146.50. Read More.
- Cadence Bancorporation (NYSE:CADE) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $22.05. Read More.
- Cadence Bancorporation (NYSE:CADE) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $25.00 price target on the stock, up previously from $24.00.This represents a 13.4% upside from the current price of $22.05. Read More.
- EHang (NASDAQ:EH) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.The current price is $28.31. Read More.
- Epiroc AB (publ) (OTCMKTS:EPOKY) was downgraded by analysts at Pareto Securities from a "hold" rating to a "sell" rating.The current price is $23.81. Read More.
- easyJet (OTCMKTS:ESYJY) was downgraded by analysts at Liberum Capital from a "buy" rating to a "hold" rating.The current price is $12.94. Read More.
- Golar LNG (NASDAQ:GLNG) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating.The current price is $9.48. Read More.
- IDACORP (NYSE:IDA) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $105.00 price target on the stock.This represents a 5.7% upside from the current price of $99.31. Read More.
- iRhythm Technologies (NASDAQ:IRTC) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.The current price is $82.97. Read More.
- Lucira Health (NASDAQ:LHDX) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating. They now have a $9.00 price target on the stock.This represents a 3.7% downside from the current price of $9.35. Read More.
- Luminex (NASDAQ:LMNX) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.The current price is $37.02. Read More.
- Luminex (NASDAQ:LMNX) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating.The current price is $37.02. Read More.
- Public Joint Stock Company Mining and Metallurgical Company Norilsk Nickel (OTCMKTS:NILSY) was downgraded by analysts at Societe Generale from a "buy" rating to a "hold" rating.The current price is $32.69. Read More.
- Nuance Communications (NASDAQ:NUAN) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating.The current price is $52.45. Read More.
- Nuance Communications (NASDAQ:NUAN) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating.The current price is $52.45. Read More.
- NorthWestern (NASDAQ:NWE) was downgraded by analysts at Credit Suisse Group AG from an "outperform" rating to a "neutral" rating. They now have a $66.00 price target on the stock, up previously from $60.00.This represents a 1.2% downside from the current price of $66.79. Read More.
- Singapore Airlines (OTCMKTS:SINGY) was downgraded by analysts at Nomura from a "buy" rating to a "reduce" rating.The current price is $8.34. Read More.
- TuanChe (NASDAQ:TC) was downgraded by analysts at Maxim Group from a "buy" rating to a "hold" rating.The current price is $4.01. Read More.
- Yara International ASA (OTCMKTS:YARIY) was downgraded by analysts at Berenberg Bank from a "buy" rating to a "hold" rating.The current price is $25.15. Read More.
- View today's most recent analysts' downgrades at MarketBeat.com
Tiny Biotech Creates $2 Trillion Drug (ad) |
The Wall Street Journal reports new treatment is "transforming medicine."
Bill Gates writes that it could "help humanity."
Ark Investments think it could be a "$2 trillion market."
And one small company owns the patent on it.
This unknown biotech's stock is set to surge 46,751% >>> |
|
- AFC Gamma (NASDAQ:AFCG) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $28.00 price target on the stock.This represents a 21.8% upside from the current price of $22.98. Read More.
- AFC Gamma (NASDAQ:AFCG) is now covered by analysts at Seaport Global Securities. They set a "buy" rating and a $25.70 price target on the stock.This represents a 11.8% upside from the current price of $22.98. Read More.
- Aker Carbon Capture AS (OTCMKTS:AKCCF) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating on the stock.The current price is $2.00. Read More.
- Black Knight (NYSE:BKI) is now covered by analysts at Raymond James. They set a "market perform" rating on the stock.The current price is $74.29. Read More.
- Blackstone Mortgage Trust (NYSE:BXMT) is now covered by analysts at BTIG Research. They set a "buy" rating and a $35.00 price target on the stock.This represents a 9.2% upside from the current price of $32.04. Read More.
- Connect Biopharma Holdings Limited American Depositary Shares (NASDAQ:CNTB) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.The current price is $17.00. Read More.
- Connect Biopharma Holdings Limited American Depositary Shares (NASDAQ:CNTB) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $27.00 price target on the stock.This represents a 58.8% upside from the current price of $17.00. Read More.
- Connect Biopharma Holdings Limited American Depositary Shares (NASDAQ:CNTB) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $32.00 price target on the stock.This represents a 88.2% upside from the current price of $17.00. Read More.
- Coinbase Global (NASDAQ:COIN) is now covered by analysts at Moffett Nathanson. They set a "buy" rating and a $600.00 price target on the stock. Read More.
- Charter Hall Group (OTCMKTS:CTOUF) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating on the stock.The current price is $9.60. Read More.
- Citrix Systems (NASDAQ:CTXS) is now covered by analysts at Bank of America Co.. They set an "underperform" rating on the stock.The current price is $138.72. Read More.
- First Guaranty Bancshares (NASDAQ:FGBI) is now covered by analysts at DA Davidson. They set a "neutral" rating on the stock.The current price is $18.02. Read More.
- Finch Therapeutics Group (NASDAQ:FNCH) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $34.00 price target on the stock.This represents a 97.1% upside from the current price of $17.25. Read More.
- Finch Therapeutics Group (NASDAQ:FNCH) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $25.00 price target on the stock.This represents a 44.9% upside from the current price of $17.25. Read More.
- Finch Therapeutics Group (NASDAQ:FNCH) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $29.00 price target on the stock.This represents a 68.1% upside from the current price of $17.25. Read More.
- GigCapital3 (NYSE:GIK) is now covered by analysts at Northland Securities. They set an "outperform" rating and a $15.00 price target on the stock.This represents a 49.3% upside from the current price of $10.05. Read More.
- GT Biopharma (OTCMKTS:GTBP) is now covered by analysts at B. Riley. They set a "buy" rating and a $21.00 price target on the stock.This represents a 101.9% upside from the current price of $10.40. Read More.
- ICON Public (NASDAQ:ICLR) is now covered by analysts at Bank of America Co.. They set a "neutral" rating on the stock.The current price is $195.94. Read More.
- Identiv (NASDAQ:INVE) is now covered by analysts at B. Riley. They set a "buy" rating and a $21.00 price target on the stock.This represents a 68.0% upside from the current price of $12.50. Read More.
- Lumos Pharma (NASDAQ:LUMO) is now covered by analysts at Jonestrading. They set a "buy" rating and a $34.00 price target on the stock.This represents a 211.9% upside from the current price of $10.90. Read More.
- NortonLifeLock (NASDAQ:NLOK) is now covered by analysts at Bank of America Co.. They set an "underperform" rating and a $19.00 price target on the stock.This represents a 11.8% downside from the current price of $21.55. Read More.
- Playa Hotels & Resorts (NASDAQ:PLYA) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $10.00 price target on the stock.This represents a 36.1% upside from the current price of $7.35. Read More.
- Property Solutions Acquisition (NASDAQ:PSAC) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $26.00 price target on the stock.This represents a 101.1% upside from the current price of $12.93. Read More.
- Restaurant Brands International (NYSE:QSR) (TSE:QSR) is now covered by analysts at Northcoast Research. They set a "neutral" rating on the stock.The current price is $66.56. Read More.
- Regions Financial (NYSE:RF) is now covered by analysts at DA Davidson. They set a "neutral" rating on the stock.The current price is $20.92. Read More.
- Instil Bio (NASDAQ:TIL) is now covered by analysts at Truist. They set a "buy" rating and a $32.00 price target on the stock.This represents a 45.9% upside from the current price of $21.94. Read More.
- Instil Bio (NASDAQ:TIL) is now covered by analysts at Cowen Inc. They set an "outperform" rating on the stock.The current price is $21.94. Read More.
- Instil Bio (NASDAQ:TIL) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $24.00 price target on the stock.This represents a 9.4% upside from the current price of $21.94. Read More.
- Tuya (NASDAQ:TUYA) is now covered by analysts at Bank of America Co.. They set a "neutral" rating and a $25.00 price target on the stock.This represents a 31.2% upside from the current price of $19.05. Read More.
- Veru (NASDAQ:VERU) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $19.00 price target on the stock.This represents a 87.6% upside from the current price of $10.13. Read More.
- View today's most recent analysts' new coverage at MarketBeat.com
More Calendars from MarketBeat | U.S. Analyst Ratings, Canadian Analyst Ratings, U.K. Analyst Ratings, Corporate Buybacks, Cryptocurrencies, Dividend Declarations, Earnings Announcements, Earnings Conference Calls, Economic Reports, Gap Up/Down Stocks, Insider Trades, Initial Public Offerings (IPOs), Most Active Stocks, Percentage Gainers/Decliners, Sector Performance, Short Interest, Stock Splits, Unusual Options Volume & Unusual Trading Volume. |
Upgrade Your Subscription |
Upgrade to MarketBeat Daily Premium and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW |
|
|
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO | |
|
Join MarketBeat's free stock discussion and trading idea group on Facebook.
JOIN NOW | |
|
|
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.© 2006-2021 American Consumer News, LLC dba MarketBeat. 326 E 8th St #105, Sioux Falls, SD 57103. United States. |
Tidak ada komentar:
Posting Komentar